Xilin Zhao

Dr. Xilin Zhao

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YHYuzhi Hong
Yuzhi Hong
JZJie Zeng
Jie Zeng
XWXiuhong Wang
Xiuhong Wang
KDKarl Drlica
Karl Drlica
XZXilin Zhao
Xilin Zhao
Antimicrobial efficacy, which is central to many aspects of medicine, is being rapidly eroded by bacterial resistance. Since new resistance can be induced by antimicrobial action, highly lethal agents that rapidly reduce bacterial burden during infection should help restrict the emergence of resistance. To improve lethal activity, recent work has focused on toxic reactive oxygen species (ROS) as part of the bactericidal activity of diverse antimicrobials. We report that when Escherichia coli was subjected to antimicrobial stress and the stressor was subsequently removed, both ROS accumulation and cell death continued to occur. Blocking ROS accumulation by exogenous mitigating agents slowed or inhibited poststressor death. Similar results were obtained with a temperature-sensitive mutational inhibition of DNA replication. Thus, bacteria exposed to lethal stressors may not die during treatment, as has long been thought; instead, death can occur after plating on drug-free agar due to poststress ROS-mediated toxicity. Examples are described in which ( i ) primary stress-mediated damage was insufficient to kill bacteria due to repair; ( ii ) ROS overcame repair (i.e., protection from anti-ROS agents was reduced by repair deficiencies); and ( iii ) killing was reduced by anti-oxidative stress genes acting before stress exposure. Enzymatic suppression of poststress ROS-mediated lethality by exogenous catalase supports a causal rather than a coincidental role for ROS in stress-mediated lethality, thereby countering challenges to ROS involvement in antimicrobial killing. We conclude that for a variety of stressors, lethal action derives, at least in part, from stimulation of a self-amplifying accumulation of ROS that overwhelms the repair of primary damage.

1 February 2008 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
KDKarl Drlica
Karl Drlica
MMMuhammad Malik
Muhammad Malik
RKRobert J. Kerns
Robert J. Kerns
XZXilin Zhao
Xilin Zhao

1 October 2014 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
XZXilin Zhao
Xilin Zhao
KDKarl Drlica
Karl Drlica

1 March 2007 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
KDKarl Drlica
Karl Drlica
XZXilin Zhao
Xilin Zhao
The mutant selection window hypothesis postulates that, for each antimicrobial-pathogen combination, an antimicrobial concentration range exists in w

15 September 2001 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
XZXilin Zhao
Xilin Zhao
KDKarl Drlica
Karl Drlica
Studies with fluoroquinolones have led to a general method for restricting the selection of antibiotic-resistant mutants. The strategy is based on th

1 August 2009 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
KDKarl Drlica
Karl Drlica
HHHiroshi Hiasa
Hiroshi Hiasa
RKRobert Kerns
Robert Kerns
MMMuhammad Malik
Muhammad Malik
AMArkady Mustaev
Arkady Mustaev
XZXilin Zhao
Xilin Zhao
The quinolones trap DNA gyrase and DNA topoisomerase IV on DNA as complexes in which the DNA is broken but constrained by protein. Early studies suggested that drug binding occurs largely along helix-4 of the GyrA (gyrase) and ParC (topoisomerase IV) proteins. However, recent X-ray crystallography shows drug intercalating between the -1 and +1 nucleotides of cut DNA, with only one end of the drug extending to helix-4. These two models may reflect distinct structural steps in complex formation. A consequence of drug-enzyme-DNA complex formation is reversible inhibition of DNA replication; cell death arises from subsequent events in which bacterial chromosomes are fragmented through two poorly understood pathways. In one pathway, chromosome fragmentation stimulates excessive accumulation of highly toxic reactive oxygen species that are responsible for cell death. Quinolone resistance arises stepwise through selective amplification of mutants when drug concentrations are above the MIC and below the MPC, as observed with static agar plate assays, dynamic in vitro systems, and experimental infection of rabbits. The gap between MIC and MPC can be narrowed by compound design that should restrict the emergence of resistance. Resistance is likely to become increasingly important, since three types of plasmid-borne resistance have been reported.